Abstract
During the last 10 yr, we have derived monoclonal antibodies from animals immunized with denatured bovine papillomaviruses type 1 major capsid (L1) protein, mapped their corresponding immunodominant epitopes to within a single amino acid (aa), and compared the reactivity of authentic L1 proteins to the predicted response by collinear analysis of the aa sequences of the same and other papillomaviruses (PVs). The data obtained from this approach has provided us with new insights into the sensitivity and specificity of the antibody response to viral proteins. We have included here some observations and conclusions that appear to be generic for the immune response, some of which might have applications for working with linear epitopes in other experimental systems.
Article PDF
Similar content being viewed by others
References
Melnick JL: Summaries on viral taxonomy, published annually in Prog Med Virology. Basel, Switzer- land, Karger. 1966–1990.
Quinnan GV Jr: Immunology of viral infections, in: Belsche RB (ed): Textbook of Human Virol- ogy, ed 1. MA, PSG, 1984, pp 103–108.
Summaries on modern vaccines. Lancet, 1990.
Anfinsen CB, Scherga HA: Experi- mental and theoretical aspects of protein folding. Adv Prot Chem 1975;29:205–300.
Tainer JA, Getzoff ED, Paterson Y, Olson AJ, Lerner RA: The atomic mobility component of protein anti- genicity. Ann Rev Immunol 1985; 3:501–535.
Geysen HM, Tainer JA, Rodda SJ, Mason TJ, Alexander H, Getzoff ED, Lerner RA: Chemistry of anti- body binding to a protein. Science 1987;235:1184–1190.
Getzof ED, Geysen HM, Rodda SJ, Alexander H, Tainer JA, Lerner RA: Mechanisms of anti- body binding to a protein. Science 1987; 235: 1191–1196.
Geysen HM, Rodda SJ, Mason TJ, Tribbick G, Schoofs PG: Strate- gies for epitope analysis using pep- tide synthesis. J Immunol Methods 1987;102:259–274.
Pilacinski VVP, Glassman DL, Krsyzek RA, et al.: Cloning and expression inE. coli of the bovine papillomavirus L1 and L2 open reading frames. Biotechnology 1984;2:356–360.
Jenison SA, Firzlaff JM, Langen- berg A, Galloway DA: Identifi- cation of immunoreactive antigens of human papillomavirus type 6b by usingEscherichia coli-expressed fusion proteins. J Virol 1988:62: 2115–2123.
Galloway DA, Jenison SA: Char- acterization of the humoral immune response to genital papillomavi- ruses. Mol Biol Med 1990;7:59–72.
Dillner J, Dillner L, Utter G, Eklund C, Rotola A, Costa S, DiLuca D: Mapping of linear epi- topes of human papillomavirus type 16: the L1 and L2 open read- ing frames. Int J Cancer 1990;45: 529–535.
Dillner J: Mapping of linear epi- topes of human papillomavirus type 16: The El, E2, E4, E5, E6, and E7 open reading frames. Int J Cancer 1990;46:703–711.
Cason J, Patel D, Naylor J, Lun- ney D, Shepherd PS, Best JM, McCance DJ: Identification of immunogenic regions of the major coat protein of human papilloma- virus type 16 that contain type-restricted epitopes. J Gen Virol 1989;70:2973–2987.
Jochmus-Kudielka I, Schneider A, Braun R, Kimmig R, Koldovsky U, Schneweis KE, Seedorf K, Gissmann L: Antibodies against human papillomavirus type 16 early proteins in human sera: anti E7 reactivity correlates with cervi- cal cancer. J Natl Cancer Inst USA 1989;81:1698–1704.
Kreider JW, Howett MK, Wolfe SA, Bartlett GL, Zaino RJ, Sedlace KT, Mortel R: Morphological trans- formationin vivo of human uterine cervix with papillomavirus from condylomata acuminate. Nature (Lond) 1985:317:639–640.
Lim P, Jenson AB, Cowsert L, Nakai Y, Lim LY, Jin XW, Sund- berg JP: Distribution and specific identification of papillomavirus major capsid protein epitopes by immunohistochemistry and epitope scanning of synthetic peptides. J Infect Dis 1990;162: 1263–1269.
Davis D, Chaudhri B, Stephens DM, Carne CA, Willers C, Lach- mann PJ: The immunodominance of epitopes within the transmem- brane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host’s previous exposure to similar epi- topes on unrelated antigens. J Gen Virol 1990;71:1975–1983.
Cohen BD, Goldstein DJ, Rut- ledge L, Vass WC, Lowy DR, Schlegel R, Schiller JT. Transfor- mation-specific interactin of the bovine papillomavirus E5 onco- protein with the platelet-derived growth factor receptor transmem- brane domain and the epidermal growth factor receptor cytoplasmic domain. JVirol 1993;67:5303–5311.
Andersson T, Sparkowski J, Gold- stein DJ, Schlegel R: Vacuolar H(+)-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein. J Biol Chem 1995;270:6830–6837.
Sparkowski J, Mense M, Anders J, Schlegel R: E5 oncoprotein trans- membrane mutants dissociate fibroblasts transforming activity from 16-kilodalton protein bind- ing and platelet-derived growth factor receptor binding and phos- phorylation. J Virol 1996;70: 2420–2430.
Jenson AB, Lim P, Ghim S, Cowsert L, Olson C, Lim L-Y, Farquhar C, Pilacinski W: Identi- fication of linear epitopes of the BPV-1 L1 protein recognized by sera of infected or immunized animals. Pathobiol 1991;59:396–403.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jenson, A.B., Jenson, M.C., Cowsert, L. et al. Multiplicity of uses of monoclonal antibodies that define papillomavirus linear immunodominant epitopes. Immunol Res 16, 115–119 (1997). https://doi.org/10.1007/BF02786327
Issue Date:
DOI: https://doi.org/10.1007/BF02786327